Skin Cancer Treatment

Skin cancers are among the most common forms of cancer. This pathology requires timely detection and comprehensive treatment, as early diagnosis increases the chances of a full recovery.

Modern medicine offers a wide range of methods that allow for effective treatment even in complex cases. At the K+31 Medical Center (Moscow), diagnosis and treatment are based on international clinical standards and a personalized approach to each patient.

Best
specialists
Expert
equipment
Advanced diagnostic
treatment
Sign up
Fill out the entry form on the page and we will call you back
Sign up Позвонить
Download the application “Personal Account K+31”
Everything about your health in one click!
Subscribe to social networks K+31
To keep up to date with current offers and receive useful advice about your health.

What is skin cancer?

Malignant oncological disease occurs when normal skin cells degenerate into atypical ones. Under the influence of adverse factors, the cell division mechanism is disrupted, and a pathological process is triggered instead of natural tissue renewal. A tumor forms, which may appear as a spot, nodule, ulcer, or altered mole.

Unlike benign neoplasms, which are not life-threatening, malignant ones are aggressive:

  • The tumor gradually increases in size.
  • It can destroy adjacent structures (muscle, cartilage, bone).
  • It can spread through the lymph and bloodstream, forming metastases.

A distinctive feature of this type is that the skin is "visible," so many changes can be noticed at an early stage. This increases the likelihood of timely diagnosis.

Important! Regular self-examination and preventative visits to the doctor are among the most reliable ways to detect a disease at an early stage, when it is most amenable to treatment.

What is skin cancer?

Classification

Skin cancer is a heterogeneous disease that can manifest itself in different forms. Each type has its own characteristics, rate of progression, and characteristic cellular behavior. The specific type diagnosed determines the treatment strategy and prognosis.

Basal cell

Basal cell carcinoma is the most common type of skin cancer, most often appearing on exposed areas such as the face, neck, and ears. It can appear as a shiny nodule, a pink spot, or a non-healing ulcer.

It is characterized by slow growth and extremely rare metastasis. However, basal cell carcinoma can destroy adjacent tissue if left untreated.

Squamous cell

This is a more aggressive type of tumor, developing from the cells of the superficial layer. Unlike basal cell carcinoma, this type more often spreads to the lymph nodes and can metastasize to internal organs.

Appearances vary: a dense nodule, an ulcer with jagged edges, or a wart-like growth. Squamous cell carcinoma most often occurs in areas exposed to prolonged ultraviolet rays or chronic inflammation.

Melanoma

One of the most dangerous forms develops from melanocytes—the cells responsible for producing the pigment melanin.

The main signs of melanoma:

  • Changes in the shape, color, or size of the mole
  • Asymmetry, jagged edges, itching, and bleeding
  • Rapid enlargement of the pigmented spot

Even in the early stages, melanoma is prone to aggressive metastasis, affecting the lymph nodes, lungs, liver, and brain. Every week of delay reduces the chances of success.

Merkel cell tumors

This rare but extremely aggressive malignancy originates in specialized neuroendocrine cells. It is more common in older adults and patients with weakened immune systems.

A Merkel cell tumor appears as a firm, painless, red or purple nodule that can rapidly enlarge. The disease is characterized by early metastasis.

Metatypic

This type occupies an intermediate position between basal cell and squamous cell types. It is less common, but has an unpredictable course.

It can present as a nodule or ulcer, gradually increasing in size. Unlike pure basal cell carcinoma, it is more likely to metastasize, but with timely, qualified treatment, the prognosis remains favorable.

Important! Correctly determining the type plays a key role in choosing a treatment strategy. Therefore, diagnosis and consultation with an experienced physician are essential for every patient diagnosed with a suspicious neoplasm.

Skin cancer diagnosis

A thorough examination is a key step in establishing an accurate diagnosis and choosing the optimal treatment approach. K+31 Medical Center uses modern equipment that allows us to detect tumors even in the early stages of development.

Skin cancer diagnosis involves several stages:

  • A doctor's examination to assess the tumor's appearance, shape, color, and structure.
  • Dermatoscopy. Using a special instrument called a dermatoscope, the doctor examines the tumor under high magnification.
  • A biopsy is the primary method for confirming the diagnosis. The skin area with the suspicious change is excised and then sent to a laboratory for histological examination to determine the cell type and whether it is malignant.
  • CT, MRI, and PET-CT are used to assess the depth of the lesion and detect metastases.
  • Laboratory tests. Blood tests, including tumor markers, are often prescribed to determine the stage and activity of the disease.

No single method provides a complete picture. It is the combination of a clinical examination, biopsy, and instrumental examination that allows the doctor to accurately assess the pathology.

Diagnostics are tailored to each individual case. The physician's experience and modern equipment at the K+31 clinic guarantee an accurate diagnosis, which determines the success of subsequent medical interventions.

  • Diagnostic Features of Different Types of Cancer Different clinical cases require specific approaches.
  • Basal Cell Usually detected by dermatoscopy and confirmed by biopsy. Metastases are rare, so the focus is on the local process.
  • Squamous Cell Checking of nearby lymph nodes is mandatory.
  • Melanoma In addition to biopsy, lymph node ultrasound and PET-CT may be performed.
  • Merkel Cell Tumor Diagnosis is always comprehensive, including immunohistochemical studies.
  • Metatypic Requires careful morphological analysis to accurately determine the nature of the pathological element.

Stages of skin cancer

The stage of the disease determines how deeply the pathology has penetrated the tissue and whether it has spread to other structures. The doctor determines the depth and extent of the pathological process after an examination, biopsy, and additional tests (CT, MRI, PET-CT).

Medical classification distinguishes several stages:

  • 0 (carcinoma in situ). Cancer cells are present only in the superficial layer. This is the earliest stage, at which treatment is almost always completely curative.
  • 1. A small element (up to 2 cm), limited to the skin and does not affect the lymph nodes. With timely surgery, the prognosis is favorable.
  • 2. The size exceeds 2 cm or it shows signs of more aggressive growth, but there are no metastases yet.
  • 3. The tumor grows deeper, can affect muscle or cartilage, and spread metastases to nearby lymph nodes.
  • 4. The tumor reaches significant size, affecting distant organs (lungs, liver, bones, brain).

Important! Even in the late stages of the disease, modern treatments can prolong life, reduce the severity of symptoms, and improve quality of life.

Skin cancer treatment

The choice of treatment depends on the stage of the disease, its type, and the patient's overall condition. The earlier the diagnosis, the higher the chances of a complete cure.

The K+31 Medical Center uses a personalized approach: doctors carefully analyze the clinical picture, selecting the optimal combination.

Surgery

Surgery is one of the main treatment methods. The tumor is removed along with a small area of ​​surrounding healthy tissue to eliminate the risk of recurrence. K+31 Clinic uses modern technologies to minimize surgical trauma and preserve the aesthetic result.

Advantages of surgery for oncology:

  • Radical removal
  • Ability to control excision margins
  • Low risk of recurrence in early stages
  • Use of reconstructive techniques to restore appearance

Thanks to the use of epidural anesthesia, patients with chronic heart, kidney, and lung diseases, as well as the elderly, can safely undergo surgery.

Radiation Therapy

Radiation Therapy

Radiation therapy is used when surgery is impossible or undesirable. Using linear accelerators, radiation is directed precisely to the affected area, sparing healthy tissue.

This method is suitable for treating squamous cell tumors, Merkel cell tumors, and as a post-operative adjunct.

Chemotherapy

Special drug therapy is prescribed when the pathology extends beyond the skin layer, spreading to the lymph nodes or internal organs.

The goal of treatment is to stop the growth of malignant cells, reduce the size of the tumor, and prevent the spread of the process.

Targeted Therapy

This approach involves targeting the molecules responsible for tumor growth. Unlike chemotherapy, the drugs act precisely, damaging cancer cells.

This therapeutic approach is used for melanoma and other aggressive forms of cancer, significantly slowing the process. Targeted therapy can be administered alone or in combination with other methods, enhancing their effectiveness.

Cryosurgery

Cryosurgery

Cryosurgery involves applying liquid nitrogen to the tumor. The low temperature freezes and destroys tumor cells, causing the wound to gradually heal.

Cryosurgery is effective for small basal cell carcinomas, superficial forms, and early stages of the disease. This method is minimally invasive.

Laser Therapy

Laser is used to remove small, superficial lesions. The beam acts precisely, removing abnormal cells with minimal damage to surrounding structures.

Hardware laser therapy is especially useful for treating tumor-like lesions on the face and other exposed areas where cosmetic results are important. Laser is also used as an adjunct to surgery.

General information

Causes of Development

Skin cancer does not occur suddenly. It is the result of accumulated damage to cellular structures due to external and internal pathogenic factors. Over time, these changes can lead to the cell losing control of division. From this point on, the oncological process begins.

The main risk factors include:

  • Ultraviolet radiation. Excessive sun exposure, including in tanning beds, is the leading cause. Sunburns are especially dangerous in childhood and adolescence, when the skin is more vulnerable.
  • Fair skin phototype. People with fair skin, blue eyes, and red or blond hair have less natural protection against ultraviolet radiation, so their risk is higher.
  • Hereditary predisposition. If there is a history of cancer in the family, the risk of developing it in immediate relatives increases.
  • Age. The skin of older people has accumulated a large amount of damage, so cancer most often develops after age 60.
  • Immune disorders. People with a weakened immune system (for example, after an organ transplant or with chronic diseases) are more vulnerable to developing malignancies.
  • Exposure to carcinogens. Direct contact with chemicals (arsenic, petroleum products) increases the risk.
  • Chronic inflammation, scars, long-term non-healing burn ulcers, old injuries.
  • Ionizing radiation. High levels of radiation and frequent medical exposures can damage cellular DNA.

The presence of risk factors does not necessarily mean that cancer will develop. But understanding the causes helps take preventative measures in a timely manner.

Symptoms, Signs

In the early stages of development, the neoplasm may look like a harmless skin defect: moles, warts, eczema, cracks. This is why many patients put off visiting a doctor.

Typical signs include:

  • The appearance of a new element that gradually grows
  • Change in color, shape, or size of a mole
  • A lump or nodule that does not go away
  • An ulcer or erosion that does not heal for more than 3-4 weeks
  • A formation with uneven, blurred edges
  • Itching, burning, or pain in the area of the neoplasm
  • Bleeding or fluid discharge from the nodule or spot

Signs can appear on any part of the body, but malignant processes most often occur in exposed areas.

Unobvious symptoms

There are less noticeable manifestations that can also indicate the development of cancer Process:

  • A feeling of tightness in a localized area
  • The appearance of new pigment spots that differ from the rest
  • Asymmetry, uneven coloring of moles
  • Peeling, formation of a thick crust without apparent cause
  • Mild chronic inflammation around a mole or spot

Patients often attribute these symptoms to allergies, dermatitis, or injury. However, they are often the first signs of illness.

Prevention

Prevention is an effective way to reduce the risk of developing malignant processes. Enhanced protective measures are especially important for high-risk groups: those with fair skin, those with a family history of frequent sunburn, and chronic skin conditions.

Basic recommendations for cancer prevention:

  • UV protection: use sunscreens with a high SPF, wear long sleeves, wear hats, and wear sunglasses with a UV filter. It's important to avoid direct sun exposure between 10:00 AM and 4:00 PM. li>
  • Limiting tanning bed visits. li>
  • Monthly self-examination of your skin and moles can help identify suspicious changes early. li>
  • Promptly consult a doctor about any growth that grows, changes color or shape, bleeds, or doesn't heal. li>
  • Maintain healthy skin. Avoiding chronic inflammation, promptly treating injuries and burns, and protecting yourself from chemical irritants reduce the risk of cell degeneration. li>
  • Maintaining a healthy lifestyle. Proper nutrition, weight control, quitting smoking, and moderate physical activity help maintain immunity.

Regular adherence to these measures not only reduces the risk of skin cancer but also improves the effectiveness of early detection.

Specialists at the K+31 Clinic conduct consultations, educating patients on proper preventative measures.

Important! Prevention does not preclude regular medical monitoring. Even with all protective measures in place, it is necessary to have an oncologist examine you once or twice a year, especially for those in high-risk groups.

Prognosis, Survival

The prognosis for cancer depends on several factors.

Prognosis by skin cancer type:

  • Basal cell cancer almost never spreads throughout the body. With timely surgical intervention, the five-year survival rate for patients exceeds 95%. Even in rare cases of metastasis, the risk of their development is extremely low.
  • Squamous cell cancer is characterized by a more aggressive course. In the early stages, the five-year survival rate reaches 90–95%. If the tumor has spread to the lymph nodes, the rate drops to 40–78%, while with distant metastases it is less than 20%.
  • With melanoma, the five-year survival rate varies greatly depending on the stage: with early melanoma (stage 1), it reaches 90–95%, with stage 2, it is 70–80%, with stage 3, it is 40–60%, and with distant metastases (stage 4), it is approximately 15–20%. Modern techniques, including immunotherapy and targeted drugs, can significantly improve the prognosis, especially with early tumor detection.
  • With timely treatment, 80% of Merkel cell tumors will be cured or stopped in long-term remission. With metastases to the lymph nodes or internal organs, the prognosis worsens.
  • With metatypic disease, early detection and the absence of metastases allows for a high survival rate. With an aggressive course and spread throughout the body, the likelihood of a successful outcome decreases.

Early treatment and adequate therapy significantly increase the chances of a complete cure (80-100%) or long-term remission. Late presentation, especially if the tumor has spread to the lymph nodes or internal organs, reduces the likelihood of a successful outcome.

Factors Affecting Prognosis

The following factors influence the outcome of the disease:

  • Tumor stage
  • Type (basal cell carcinoma usually has a more favorable prognosis, while melanoma requires immediate comprehensive therapy)
  • Patient's general condition
  • Timeliness of medical care

At the K+31 Medical Center, patients receive comprehensive care, including modern diagnostics (CT, MRI, PET-CT), surgical techniques, radiation therapy, and chemotherapy. New treatment approaches, such as targeted therapy and immunotherapy, are also used. An individualized approach and ongoing specialist monitoring help increase the effectiveness of therapy, improving the prognosis for each patient.

Post-Treatment Rehabilitation

After completion of treatment, the rehabilitation phase begins, which is no less important than the treatment itself. It is aimed at restoring the body, normalizing skin function, preventing complications, and reducing the risk of disease recurrence. Rehabilitation helps patients return to their normal lives and maintain a high level of health.

Main areas of rehabilitation:

  1. Medical monitoring (regular examinations with an oncologist)
  2. Skin restoration (using moisturizers, healing agents, mild antiseptics, and, if necessary, cosmetic procedures)
  3. Physiotherapy (massage, microcurrent therapy, gentle UV irradiation)
  4. Maintenance medication therapy (vitamins, immunostimulants, medications to support liver and kidney function)
  5. Psychological support. At the K+31 center, patients receive consultations with a psychologist, can participate in support groups, and are trained in strategies for adapting to changes in appearance and lifestyle after treatment.

The K+31 clinic offers day and 24-hour inpatient care, comfortable rooms for one or two people, the option of staying with a family member, ongoing staff monitoring, and regular visits with the attending physician.

This approach not only ensures safe recovery but also reduces the risk of relapse, helping patients quickly return to an active life.

Bibliography:

  1. Lamotkin I. A. Clinical Dermato-Oncology. Moscow: BINOM. Laboratory of Knowledge, 2013. 499 p.
  2. Cherenkov V. G. Clinical Oncology. Moscow: MK, 2010. 434 p.
  3. Chissov V. I. Oncology. Moscow: GEOTAR-Media, 2007. 560 p.
  4. Gilyazutdinov I. A., Khasanov R. Sh., Safin I. R., Moiseev V. N. Malignant Tumors of Soft Tissue and Skin Melanoma. — Moscow: Practical Medicine, 2010. — 204 p.
  5. Polyakov A. P., Gevorkov A. R., Stepanova A. A. Modern strategy for the diagnosis and treatment of squamous cell skin cancer // Tumors of the head and neck. - 2021. - Vol. 11. - No. 1. - Pp. 51-72.
  6. Utyashev I. A. et al. Malignant non-melanocytic tumors of the skin (basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma) // Malignant tumors. - 2023. - Vol. 13. - No. 3s2-1. – P. 311-334.
  7. Kubanov A. A. et al. Current understanding of the pathogenesis of basal cell skin cancer // Bulletin of dermatology and venereology. – 2021. – Vol. 97. – No. 5. – P. 38-51.
  8. Ignatova A. V. Actual problems of treatment of locally advanced and metastatic squamous cell skin cancer // Modern oncology. – 2021. – Vol. 23. – No. 1. – P. 94-98.
  9. Gevorkov A. R. et al. Radiation therapy of squamous cell skin cancer: current standards and future prospects // Tumors of the head and neck. – 2022. – Vol. 12. – No. 3. – P. 53-70.

Questions and Answers

How can I tell if a tumor may be malignant?

Oncology can manifest as a mole or spot that changes color, shape, size, or begins to bleed. Any new growth that does not heal within 3-4 weeks requires examination by an oncologist. Even a single suspicious case requires diagnosis.

What treatment methods are used in modern medicine?

Methods include surgical removal of the tumor, radiation therapy, chemotherapy, targeted and immunotherapy, as well as cryosurgery and laser therapy for superficial forms. At K+31, treatment is individually tailored based on the tumor type, stage, and the patient's overall condition.

What is post-treatment rehabilitation like?

Rehabilitation includes skin restoration, physical therapy, supportive medication therapy, and psychological support. Patients are constantly monitored by medical staff, which helps minimize complications and reduce the risk of recurrence.

How often should I have post-treatment checkups?

The doctor recommends follow-up examinations once or twice a year, but in high-risk patients or after aggressive tumors, visits may be more frequent. The goal is to detect any new changes early and prevent recurrence.

How important is the role of heredity in the development of skin cancer?

A hereditary predisposition increases the risk, especially if there is a family history of melanoma or other forms of skin cancer. This does not necessarily mean the disease will develop, but it does require regular monitoring and preventative measures.

Can skin cancer be cured completely?

Yes, especially if diagnosed early.

What are the most effective treatments?

The choice depends on the type and stage of the tumor. Surgery is most often used, sometimes in combination with radiation or chemotherapy.

Is it necessary to remove all tumors?

Each case is individual. The decision is made by the doctor after diagnosis.

Can outpatient treatment be performed?

Some treatments are possible in a day hospital, but complex cases require 24-hour monitoring.

Our doctors

Merkulov Igor Alexandrovich
Experience 34 years
Make an appointment
Merkulov
Igor Alexandrovich
Deputy Chief Physician for Oncology, Oncologist
Ershova Ksenia Igorevna
Experience 23 years
Make an appointment
Ershova
Ksenia Igorevna
Head of department, oncologist
Abashin Sergey Yuryevich
Experience 43 years
Make an appointment
Abashin
Sergey Yuryevich
Head of oncology projects, oncologist
Kalakutskaya Natalia Lvovna
Experience 28 years
Make an appointment
Kalakutskaya
Natalia Lvovna
Doctor-oncologist
Malygin Sergey Evgenyevich
Experience 31 year
Make an appointment
Malygin
Sergey Evgenyevich
Oncologist-mammologist, surgeon
Pshikhachev Ahmed Mukhamedovich
Experience 23 years
Make an appointment
Pshikhachev
Ahmed Mukhamedovich
Urologist, Oncologist
Shevchuk Alexei Sergeyevich
Experience 26 years
Make an appointment
Shevchuk
Alexei Sergeyevich
Oncogynecology consultant, obstetrician-gynecologist
Chichkanova Tatyana Vladimirovna
Experience 25 years
Make an appointment
Chichkanova
Tatyana Vladimirovna
Oncologist-mammologist, radiologist
Ovsiy Oksana Gennadievna
Experience 14 years
Make an appointment
Ovsiy
Oksana Gennadievna
Doctor-oncologist
Katz Ksenia Vladimirovna
Experience 12 years
Make an appointment
Katz
Ksenia Vladimirovna
Dermatovenerologist, oncologist
Korshikova Kamila Mukhtorovna
Experience 5 years
Make an appointment
Korshikova
Kamila Mukhtorovna
Radiotherapist
Ter-Arutyunyants Svetlana Andreevna
Experience 27 years
Make an appointment
Ter-Arutyunyants
Svetlana Andreevna
Radiotherapist, oncologist
Udin Oleg Ivanovich
Experience 32 years
Make an appointment
Udin
Oleg Ivanovich
Deputy chief physician for surgery, surgeon
Kogonia Lali Mikhailovna
Experience 52 years
Make an appointment
Kogonia
Lali Mikhailovna
Chemotherapist
Volkova Daria Mikhailovna
Experience 17 years
Make an appointment
Volkova
Daria Mikhailovna
Head of the Department of Radiation Therapy, Radiotherapist
Gomov
Mikhail Alexandrovich
Consultant in oncogynecology, obstetrician-gynecologist
Menkes (Ryabova) Yulia Alexandrovna
Experience 5 years
Make an appointment
Menkes (Ryabova)
Yulia Alexandrovna
Oncologist-chemotherapist
Grishin Igor Igorevich
Experience 33 years
Make an appointment
Grishin
Igor Igorevich
Obstetrician-gynecologist
Achba Maya Otarovna
Experience 18 years
Make an appointment
Achba
Maya Otarovna
Radiologist, ultrasound diagnostician, oncologist-mammologist
Lukyanenko Vladimir Alexandrovich
Experience 18 years
Make an appointment
Lukyanenko
Vladimir Alexandrovich
Oncologist-mammologist
Volenko Ivan Alexandrovich
Experience 15 years
Make an appointment
Volenko
Ivan Alexandrovich
Surgeon-oncologist-mammologist, plastic surgeon
Khailova Maria Sergeevna
Experience 5 years
Make an appointment
Khailova
Maria Sergeevna
Oncologist
Peshkova Marina Sergeevna
Experience 3 years
Make an appointment
Peshkova
Marina Sergeevna
Oncologist
Yakovleva Yana Sergeevna
Experience 8 years
Make an appointment
Yakovleva
Yana Sergeevna
Radiotherapist
Ivanova Olga Vladimirovna
Experience 26 years
Make an appointment
Ivanova
Olga Vladimirovna
Radiotherapist
Magdiev Arslan Khulatdaevich
Experience 14 years
Make an appointment
Magdiev
Arslan Khulatdaevich
Surgeon, oncologist, phlebologist
Morozova Albina Soslanovna
Experience 18 years
Make an appointment
Morozova
Albina Soslanovna
Acting head of the department of antitumor drug therapy, oncologist
Iluridze Georgy Davidovich
Experience 9 years
Make an appointment
Iluridze
Georgy Davidovich
Oncologist, traumatologist-orthopedist, surgeon
Alferov Anton Sergeevich
Experience 16 years
Make an appointment
Alferov
Anton Sergeevich
Leading urologist, andrologist
Gabaraev Alan Petrovich
Experience 13 years
Make an appointment
Gabaraev
Alan Petrovich
Urologist, andrologist
Balkarov Beslan Khasenovich
Experience 17 years
Make an appointment
Balkarov
Beslan Khasenovich
Surgeon, oncologist
Nemenov Alexander Alexandrovich
Experience 7 years
Make an appointment
Nemenov
Alexander Alexandrovich
Urologist, oncologist (oncourologist)
Melkonyan Lia Eduardovna
Experience 13 years
Make an appointment
Melkonyan
Lia Eduardovna
Oncologist, oncologist-mammologist, surgeon, radiologist, ultrasound diagnostician
Sokorutov Vasily Ivanovich
Experience 22 years
Make an appointment
Sokorutov
Vasily Ivanovich
Oncologist
Mashkey Maria Igorevna
Experience 2 years
Make an appointment
Mashkey
Maria Igorevna
Oncologist
All specialists
2GIS Award
2GIS Award

This award is given to clinics with the highest ratings according to user ratings, a large number of requests from this site, and in the absence of critical violations.

«Good place» according to Yandex
«Good place» according to Yandex

This award is given to clinics with the highest ratings according to user ratings. It means that the place is known, loved, and definitely worth visiting.

Our doctors are laureates of the ProDoctors Award
Our doctors are laureates of the ProDoctors Award

The ProDoctors portal collected 500 thousand reviews, compiled a rating of doctors based on them and awarded the best. We are proud that our doctors are among those awarded.

Make an appointment at a convenient time on the nearest date

News

20 june 2025 year
Possibilities of re-irradiation in case of recurrent glioblastoma
Author: Volkova Daria Mikhailovna, radiotherapist, head of the radiation therapy department of K31 City.
22 january 2025 year
Briefly about sarcomas in patients with Lynch syndrome
Khailova Maria Sergeevna, oncologist, Department of Antitumor Drug Therapy, K31 City.
17 january 2025 year
Perspective: More than a conference

Our head of the radiation therapy department, Daria Mikhailovna Volkova, recently returned from the conference "Prospect is more than a conference" in Kazan. There she represented our clinic K+31, sharing her experience and knowledge.

At the conference, Daria Mikhailovna gave a report on the topic: "Clinical case of CRT in unresectable NSCLC".

27 december 2024 year
A new approach to the treatment of soft tissue sarcomas
Sarcomas are a rare and heterogeneous group of malignant tumors: less than 1% of all malignant neoplasms in adults. Such a rare occurrence of this nosology makes it difficult to conduct large-scale studies, so each positive result of scientific work is worth its weight in gold.
17 december 2024 year
Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer
Metastatic castration-resistant prostate cancer (mCRPC) is commonly resistant to immune checkpoint inhibitors (ICIs).
01 december 2024 year
Results of the round table K+31 West “Non-oncological problems of cancer patients”
The K+31 West Clinic held a scientific and practical conference that brought together leading experts in the field of oncology, gynecology, radiotherapy, cardiology and other areas. The event discussed modern approaches to the diagnosis and treatment of oncological diseases, as well as issues of interdisciplinary interaction.
29 november 2024 year
177Lu-PSMA-617 versus androgen axis inhibitor in the treatment of taxane-naïve advanced metastatic castration-resistant prostate cancer
Prostate-specific membrane antigen (PSMA) is a well-studied cell membrane antigen specific for prostate cancer (PCa) and is not found in other tissues of the body.
09 november 2024 year
Are the long-term oncologic outcomes different between neoadjuvant chemotherapy and adjuvant chemotherapy in locally advanced breast cancer?
Today's post is prompted by the question: "Is there a difference in cancer outcomes depending on the sequence of chemotherapy and surgery?"
26 october 2024 year
Neoadjuvant therapy with nivolumab + relatlimab or nivolumab + ipilimumab in triple-negative breast cancer
In triple-negative breast cancer (TNBC), the addition of immunotherapy to neoadjuvant chemotherapy improves pathological complete response (pCR) rates...
13 october 2024 year
Breakthrough in oncology: treatment of metastatic melanoma with the drug "Nurdati"
Recently, a young patient with a relapse of metastatic melanoma came to the K+31 West clinic. After successful remission on targeted drugs, the disease made itself felt again. An important task arose - to choose a new approach to treatment...
07 october 2024 year
The influence of progesterone receptor levels on prognosis in patients with advanced breast cancer
A CDK4/6 inhibitor in combination with endocrine therapy is the standard first-line therapy for patients with advanced hormone-receptor-positive (HR) breast cancer...
07 october 2024 year
VII International Forum of Oncology and Radiotherapy “For Life – For Life”
The forum is a significant event in the oncology industry, the oncologist, radiotherapist of the K+31 Clinic - Svetlana Andreevna Ter-Arutyunyants spoke.
27 september 2024 year
Hematological toxicity of chemotherapy in patients with breast and ovarian cancer
BRCA1 and BRCA2 are tumor suppressor genes that play a central role in repairing double-stranded DNA breaks through homologous recombination, a fundamental DNA repair process that maintains genome integrity and, in particular, prevents possible tumor transformation of cells. Defects and mutations in these genes significantly increase the risk of developing cancer of various organs. According to some data, the prevalence of pathogenic variants in these genes in the Russian population is 1:300 for the BRCA1 gene and 1:800 for the BRCA2 gene.
17 september 2024 year
Real-World Outcomes of Lenvatinib and Anti-PD-1 Therapy in Patients With Advanced Melanoma
There are currently no treatment options for patients with advanced melanoma who have failed immunotherapy or targeted therapy.
20 august 2024 year
K+31 West held a special excursion for high school students from the “First Movement” together with RUDN University
Our future doctors saw the international level of medical services, looked into the radiology department, where cancer is treated according to world standards, and learned about advanced diagnostic methods.
15 august 2024 year
Preoperative iron supplementation is better for treating iron deficiency anemia
Iron administration is associated with a significant reduction in 30-day postoperative mortality and morbidity compared with red blood cell transfusion
11 august 2024 year
How to apply for oncology treatment under compulsory medical insurance in Moscow: instructions
According to Russian law, citizens of the country can receive medical care in the event of detection of an oncological disease at the expense of the compulsory medical insurance, and patients from the regions can apply for treatment in Moscow.
07 august 2024 year
Oncology news digest 04.08.2024
Amivantamab plus Lasertinib versus Osimertinib for first-line treatment of EGFR-mutated advanced NSCLC.
04 august 2024 year
Oncology news digest 07/21/2024

Long-term results of adjuvant therapy with dabrafenib and trametinib in stage III melanoma. COMBI-AD study.

21 july 2024 year
Oncology news digest 07/07/2024
Neoadjuvant nivolumab and ipilimumab for resectable stage III melanoma
07 july 2024 year
Oncology news digest 30.06.2024
A randomized, double-blind, placebo-controlled, phase II trial of oxybutynin versus placebo for the treatment of hot flashes in men receiving androgen deprivation therapy.
30 june 2024 year
Effect of Omega-3 Fatty Acid Diet on Prostate Cancer Progression
Involvement of tumor-associated macrophages and GPR120 dependence in the tumor microenvironment.
27 june 2024 year
The right to quality of life: K+31 hosted a round table for doctors on pain management in cancer patients

Top experts from K+31 and other clinics discussed a personalized approach to the assessment and treatment of pain in cancer patients.

29 may 2024 year
Obesity and the risk of developing cancer: what is the impact of body mass index, risks and features

Obesity is a chronic disease characterized by excessive accumulation of fatty tissue in the body.

15 march 2024 year
Thyroid cancer: types, symptoms, treatment methods

Formations (so-called nodes) in the thyroid gland are often benign in nature, however, they require regular monitoring. It is important to carry out additional studies in a timely manner (including a biopsy of suspicious nodes) in order to diagnose cancer in a timely manner. process and begin appropriate treatment.

14 march 2024 year
How to diagnose pancreatic cancer in the early stages: first symptoms and diagnostic methods

Oncopathology of this type is complicated by the location of the affected organ. Carrying out the operation requires high qualifications specialist and is often dangerous to the patient’s health. In addition, it is difficult to diagnose the disease at an early stage. not always, since the pathology develops over many years asymptomatically, and the appearance of the first signs may already indicate stage 3 or 4.

05 march 2024 year
Malignant bone tumors - symptoms, diagnosis, modern methods of therapy

Bone tumor is a collective name for malignant and benign tumors that affect skeletal bone tissue (bone or cartilage). Malignant bone tumors are called sarcomas.

02 march 2024 year
What is epidural anesthesia?

This type of anesthesia has become widely known due to its use in obstetrics and gynecology, as it is widely used to facilitate labor.

01 march 2024 year
Stomach cancer: symptoms, modern methods of diagnosis and therapy

In order to timely detect and effectively eliminate oncological pathology, it is recommended to undergo regular examinations and be observed by specialists if there is discomfort in the gastrointestinal tract.

14 february 2024 year

Price

Reception
Price
Primary oncologist appointment
from 5 900 ₽
Repeated appointment with an oncologist
from 5 900 ₽

To get a consultation

Fill out the form, our managers will contact you within 15 minutes

Reviews

I want to thank the doctor for the professional operation. Everything went smoothly, carefully, and without unnecessary stress. The doctor explained each step in detail and was always available during the recovery period. His very attentive and humane attitude is especially valuable.
26.01.2026
K. Alan Vladimirovich

About doctor:

Gabaraev Alan Petrovich

a great doctor with golden hands!
21.01.2026
G. Olga Alexandrovna
Akhmedkhan Mukhamedovich masterfully performed a renal cell carcinoma resection. A modest, wonderful man.
15.01.2026
B. Vitaly Vladimirovich
No words needed, the ratings speak for themselves. A magnificent doctor and a wonderful person.
15.01.2026
B. Vitaly Vladimirovich
A huge thank you to Anton Sergeevich Alferov for his attention to his patients. He is a true professional.
14.01.2026
Olga

About doctor:

Alferov Anton Sergeevich

Good and responsive doctor!
29.12.2025
S. Irina Viktorovna

About doctor:

Melkonyan Lia Eduardovna

Every visit is comfortable
19.12.2025
R. Elizaveta Alexandrovna

About doctor:

Achba Maya Otarovna

Maya Otarovna is a very attentive doctor. She explained everything thoroughly and expertly and answered all my questions. Thank you for your advice, patience, and attention.
17.12.2025
B. Natalia Ivanovna

About doctor:

Achba Maya Otarovna

Competent, explained clearly, gave recommendations for further treatment
16.12.2025
Ch. Valery Vasilievich
Very sweet, she helped me!!!
14.12.2025
I. Khamisa Nasrulaevna

About doctor:

Katz Ksenia Vladimirovna

Почему К+31?
К + 31 — full-cycle multidisciplinary medical centers, including the possibility of providing medical services of European quality level.
К + 31 — are leading doctors and diagnostics using high-tech equipment from world manufacturers (Karl Storz, Olympus, Siemens, Toshiba, Bausch&Lomb, Technolas, Zeiss, Topcon).
К + 31 — is ethical. The staff of K+31 clinics maintain open relationships with patients and partners. An individual approach to each patient is the basis of our service standards.
К + 31 — is modernity. On call 24/7: call center operators will answer your questions at any time and book you an appointment with doctors. Contact us by phone, through the feedback form on the website and Max.

Our clinics

K+31 on Lobachevskogo

st. Lobachevskogo, 42/4

+7 499 999-31-31

Subway
1
11
Prospect Vernadsky Station
By a car
Lobachevsky, we pass the first barrier (security post of the City Clinical Hospital No. 31), turn right at the second barrier (security post K+31)
Parking pass
Opening hours
Mon-Fri: 08:00 – 21:00
Saturday: 09:00 – 19:00
Sunday: 09:00 – 18:00
K+31 Petrovskie Vorota

1st Kolobovsky pereulok, 4

74999993131

Subway
9
Tsvetnoy Bulvar
10
Trubnaya
By a car
Moving along Petrovsky Boulevard, turn onto st. Petrovka, right after - on the 1st Kolobovsky per. Municipal parking
Opening hours
Mon-Fri: 08:00 – 21:00
Sat-Sun: 09:00 – 19:00
K+31 West

Orshanskaya, 16/2; Ak. Pavlova, 22

74999993131

Subway
3
Molodezhnaya
By a car
Moving along Orshanskaya street, we turn to the barrier with the guard post K+31. You do not need to order a pass, they will open it for you
Opening hours
Mon-Fri: 08:00 – 21:00
Sat-Sun: 09:00 – 18:00
Didn't find the service you were looking for?

Экстренная помощь